相关实验视频

Updated: Jun 4, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

基于膀癌的雄激素反应基因和查潜在的向药物的预后特征

Jiang Zhao^1,2,3, Qian Zhang⁴, Cunle Zhu¹

¹Department of Urology, Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-Communicable Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.

|December 19, 2024

概括

雄激素敏感基因 (ARG) 显著影响膀癌 (BLCA) 的进展和患者的预后. 一个已建立的ARG风险模型准确地预测了BLCA的结果和指导治疗.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
免疫学免疫学免疫学

背景情况:

膀癌 (BLCA) 不成比例地影响男性.
在BLCA进展和预后中,雄激素敏感基因 (ARG) 的作用尚不清楚.

研究的目的:

为确定BLCA预后建立一个雄激素签名.
调查ARG在BLCA中的生物功能和预后价值.

主要方法:

使用TCGA和GEO数据集进行BLCA测序数据分析.
雇佣了Cibersort和ssGSEA进行瘤微环境评估.
使用考克斯和LASSO回归分析构建了一个预后风险评分模型.
进行药物敏感性分析和实时定量PCR.

主要成果:

确定了可能调节BLCA进展的特定ARG (例如CDK6,FADS1).
证明ARG表达模式与免疫细胞透相关.
开发的风险模型准确地预测了高风险BLCA患者的更糟糕的预后,增加的肌肉透和丰富的生物功能.
使用单细胞RNA,散装RNA和PCR分析验证了风险模型,建立了一个临床名录.
预测高风险患者对弗鲁达拉,AZD8186和卡慕斯的良好反应.

结论:

在BLCA进展,免疫透和患者预后方面,ARG至关重要.
基于ARG的风险模型为预测BLCA预后提供了高准确度.
该模型为BLCA治疗中更有效的药物治疗策略提供了宝贵的指导.

关键词:

对于雄激素敏感的基因.膀癌是一种癌症.药物敏感性药物敏感性免疫细胞的透.男人男人男人男人男人预后预后预测预测瘤微环境是一个微环境.

更多相关视频

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...